JP2023134735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023134735A5 JP2023134735A5 JP2023117421A JP2023117421A JP2023134735A5 JP 2023134735 A5 JP2023134735 A5 JP 2023134735A5 JP 2023117421 A JP2023117421 A JP 2023117421A JP 2023117421 A JP2023117421 A JP 2023117421A JP 2023134735 A5 JP2023134735 A5 JP 2023134735A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- seq
- amino acid
- acid sequence
- scfv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000040430 polynucleotide Human genes 0.000 claims 22
- 108091033319 polynucleotide Proteins 0.000 claims 22
- 239000002157 polynucleotide Substances 0.000 claims 22
- 125000003275 alpha amino acid group Chemical group 0.000 claims 13
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 210000002865 immune cell Anatomy 0.000 claims 4
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 3
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 3
- 210000000822 natural killer cell Anatomy 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004039 Caspase-9 Human genes 0.000 claims 1
- 108090000566 Caspase-9 Proteins 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000004068 intracellular signaling Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762536934P | 2017-07-25 | 2017-07-25 | |
| US62/536,934 | 2017-07-25 | ||
| JP2020503988A JP2020530989A (ja) | 2017-07-25 | 2018-07-25 | 強化されたキメラ抗原受容体およびその使用 |
| PCT/US2018/043779 WO2019023396A1 (en) | 2017-07-25 | 2018-07-25 | ENHANCED CHIMERIC ANTIGENIC RECEPTORS AND USES THEREOF |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020503988A Division JP2020530989A (ja) | 2017-07-25 | 2018-07-25 | 強化されたキメラ抗原受容体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023134735A JP2023134735A (ja) | 2023-09-27 |
| JP2023134735A5 true JP2023134735A5 (enExample) | 2024-05-20 |
Family
ID=65040821
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020503988A Withdrawn JP2020530989A (ja) | 2017-07-25 | 2018-07-25 | 強化されたキメラ抗原受容体およびその使用 |
| JP2023117421A Pending JP2023134735A (ja) | 2017-07-25 | 2023-07-19 | 強化されたキメラ抗原受容体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020503988A Withdrawn JP2020530989A (ja) | 2017-07-25 | 2018-07-25 | 強化されたキメラ抗原受容体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240336699A1 (enExample) |
| EP (2) | EP3658163A4 (enExample) |
| JP (2) | JP2020530989A (enExample) |
| KR (1) | KR20200032174A (enExample) |
| CN (2) | CN118206655A (enExample) |
| AU (1) | AU2018306307B2 (enExample) |
| CA (1) | CA3070998A1 (enExample) |
| TW (1) | TW201908335A (enExample) |
| WO (1) | WO2019023396A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3883955A1 (en) * | 2018-11-19 | 2021-09-29 | Board of Regents, The University of Texas System | A modular, polycistronic vector for car and tcr transduction |
| EP4018198A1 (en) | 2019-08-21 | 2022-06-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Methods for detecting, quantifying and monitoring immune-cell mediated cytotoxicity of cell populations comprising immune cells and/or stem cells |
| NL2023924B1 (nl) * | 2019-10-01 | 2021-06-01 | Lely Patent Nv | Meetsysteem voor levensmiddelen |
| CN115461361B (zh) * | 2020-05-08 | 2025-03-14 | 玛希敦大学 | 嵌合抗原受体和携带该受体的经修饰的细胞 |
| KR102297396B1 (ko) * | 2020-07-29 | 2021-09-06 | (주)티카로스 | 면역시냅스를 안정화시키는 키메라 항원 수용체(car) t 세포 |
| CA3201621A1 (en) | 2020-12-03 | 2022-06-09 | Century Therapeutics, Inc. | Genetically engineered cells and uses thereof |
| US20220195396A1 (en) * | 2020-12-03 | 2022-06-23 | Century Therapeutics, Inc. | Genetically Engineered Cells and Uses Thereof |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| CN113980134B (zh) | 2020-12-11 | 2022-05-31 | 广州百暨基因科技有限公司 | 抗cll1抗体及其应用 |
| CN113234169B (zh) * | 2020-12-11 | 2022-11-01 | 广州百暨基因科技有限公司 | 靶向cll1嵌合抗原受体及其应用 |
| US20220333074A1 (en) | 2021-04-07 | 2022-10-20 | Century Therapeutics, Inc. | Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem Cells |
| AU2022253891A1 (en) | 2021-04-07 | 2023-08-24 | Century Therapeutics, Inc. | Gene transfer vectors and methods of engineering cells |
| WO2022216514A1 (en) | 2021-04-07 | 2022-10-13 | Century Therapeutics, Inc. | Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells |
| JP2024514203A (ja) * | 2021-04-14 | 2024-03-28 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | Ｃｄ５陽性がんを標的とするキメラ抗原受容体 |
| AR127745A1 (es) * | 2021-10-18 | 2024-02-28 | Kite Pharma Inc | Dominios de señalización para receptores quiméricos de antígenos |
| CA3243966A1 (en) | 2021-12-29 | 2023-07-06 | Century Therapeutics, Inc. | Genetically modified cells with anti-CD19/anti-CD22 chimeric antigenic receptors, and their uses |
| WO2023240212A2 (en) | 2022-06-08 | 2023-12-14 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof |
| CA3257650A1 (en) | 2022-06-08 | 2023-12-14 | Century Therapeutics, Inc. | Immunoeffector cells derived from genetically modified, multipotential stem cells with membrane IL-12 and their uses |
| WO2024102838A1 (en) | 2022-11-09 | 2024-05-16 | Century Therapeutics, Inc. | Engineered interleukin-7 receptors and uses thereof |
| CN120435498A (zh) | 2022-11-10 | 2025-08-05 | 世纪治疗股份有限公司 | 具有抗-nectin4嵌合抗原受体的基因工程化细胞及其用途 |
| WO2024240243A1 (en) * | 2023-05-25 | 2024-11-28 | Nanjing Legend Biotech Co., Ltd. | Chimeric antigen receptors and uses thereof |
| WO2025101938A2 (en) | 2023-11-10 | 2025-05-15 | Century Therapeutics, Inc. | Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof |
| WO2025106626A1 (en) | 2023-11-15 | 2025-05-22 | Century Therapeutics, Inc. | Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof |
| WO2025207798A1 (en) | 2024-03-26 | 2025-10-02 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof |
| WO2025207795A1 (en) | 2024-03-26 | 2025-10-02 | Juno Therapeutics, Inc. | Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE249840T1 (de) * | 1991-12-13 | 2003-10-15 | Xoma Corp | Verfahren und materialien zur herstellung von modifizierten variablen antikörperdomänen und ihre therapeutische verwendung |
| JP4733635B2 (ja) | 2003-07-31 | 2011-07-27 | イミューノメディクス、インコーポレイテッド | 抗ｃｄ１９抗体 |
| CA2779526C (en) * | 2009-11-03 | 2022-12-06 | City Of Hope | Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection |
| DK3473707T3 (da) * | 2012-05-25 | 2025-03-17 | Cellectis | Fremgangsmåder til engineering af allogen og immunsuppressiv resistent t-celle til immunoterapi |
| CN104853766A (zh) | 2012-10-02 | 2015-08-19 | 纪念斯隆-凯特琳癌症中心 | 用于免疫疗法的组合物和方法 |
| CN111139256A (zh) * | 2013-02-20 | 2020-05-12 | 诺华股份有限公司 | 使用人源化抗EGFRvIII嵌合抗原受体治疗癌症 |
| ES2828982T3 (es) * | 2013-05-14 | 2021-05-28 | Univ Texas | Aplicación humana de células t de receptor de antígeno quimérico (car) diseñadas |
| US10196444B2 (en) * | 2013-07-29 | 2019-02-05 | Bluebird Bio, Inc. | Multipartite signaling proteins and uses thereof |
| US20170158749A1 (en) * | 2014-04-23 | 2017-06-08 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) and methods for making and using the same |
| JP2017535284A (ja) * | 2014-11-05 | 2017-11-30 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 免疫エフェクター細胞の拡大のための遺伝子改変免疫エフェクター細胞及び遺伝子操作細胞 |
| AU2016212158B2 (en) * | 2015-01-26 | 2021-06-03 | Allogene Therapeutics, Inc. | mAb-driven chimeric antigen receptor systems for sorting/depleting engineered immune cells |
| US10786549B2 (en) * | 2015-04-23 | 2020-09-29 | Baylor College Of Medicine | CD5 chimeric antigen receptor for adoptive T cell therapy |
| MX2018006789A (es) * | 2015-12-03 | 2019-02-13 | Juno Therapeutics Inc | Receptores quimericos modificados y composiciones y metodos relacionados. |
| WO2017112877A1 (en) * | 2015-12-22 | 2017-06-29 | Icell Gene Therapeutics, Llc | Chimeric antigen receptors and enhancement of anti-tumor activity |
-
2018
- 2018-07-25 EP EP18838056.2A patent/EP3658163A4/en not_active Withdrawn
- 2018-07-25 JP JP2020503988A patent/JP2020530989A/ja not_active Withdrawn
- 2018-07-25 CN CN202410061631.8A patent/CN118206655A/zh active Pending
- 2018-07-25 CN CN201880058794.3A patent/CN111432823A/zh active Pending
- 2018-07-25 EP EP25169707.4A patent/EP4582146A2/en active Pending
- 2018-07-25 AU AU2018306307A patent/AU2018306307B2/en active Active
- 2018-07-25 WO PCT/US2018/043779 patent/WO2019023396A1/en not_active Ceased
- 2018-07-25 CA CA3070998A patent/CA3070998A1/en active Pending
- 2018-07-25 KR KR1020207005375A patent/KR20200032174A/ko not_active Ceased
- 2018-07-25 TW TW107125720A patent/TW201908335A/zh unknown
-
2023
- 2023-07-19 JP JP2023117421A patent/JP2023134735A/ja active Pending
-
2024
- 2024-06-21 US US18/750,233 patent/US20240336699A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023134735A5 (enExample) | ||
| JP2021177771A5 (enExample) | ||
| JP2024028648A5 (enExample) | ||
| JP2022027762A5 (enExample) | ||
| JP2020018311A5 (enExample) | ||
| JP6681327B2 (ja) | 抗ｐｄ−１抗体およびその応用 | |
| JP2019530431A5 (enExample) | ||
| JP2018504143A5 (enExample) | ||
| JP2021087455A5 (enExample) | ||
| JP2020503885A5 (enExample) | ||
| JP2010535032A5 (enExample) | ||
| JP2007530435A5 (enExample) | ||
| JP2017513478A5 (enExample) | ||
| JP2016512034A5 (enExample) | ||
| JP2020504101A5 (enExample) | ||
| WO2007059298B1 (en) | Chimeric immunoreceptor useful in treating human cancers | |
| JP2019525738A5 (enExample) | ||
| JP2019533989A5 (ja) | 抗ｐｄ−１抗体及びその使用 | |
| JP2013545455A5 (enExample) | ||
| CA2963798A1 (en) | Humanized anti-ox40 antibodies and uses thereof | |
| JP2018529380A5 (enExample) | ||
| JP2016511277A5 (enExample) | ||
| JP2012501669A5 (enExample) | ||
| JP2017169559A5 (enExample) | ||
| JP2013509879A5 (enExample) |